Anti-proliferative properties of kahweol in oral squamous cancer through the regulation specificity protein 1

Phytotherapy Research

Volumn 28, Issue 12, 2014, Pages 1879-1886

  Chae, Jung Il ^a   Jeon, Young Joo ^a   Shim, Jung Hyun ^b  

^a Chonbuk National University   (South Korea)

^b Mokpo National University   (South Korea)

Author keywords

Apoptosis; Coffee; Kahweol; Oral squamous cancer cell; Sp1

Indexed keywords

CASPASE 3; KAHWEOL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL XL; PROTEIN BID; TRANSCRIPTION FACTOR SP1;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG STRUCTURE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA CELL LINE;

EID: 84916242429     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5217     Document Type: Article

References (41)

1. Abdelrahim M, Smith R, 3rd, Burghardt R, Safe S. 2004. Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res 64:6740-6749.
2. Albanese C, Johnson J, Watanabe G, et al. 1995. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 270:23589-23597.
3. Andersson Y, Juell S, Fodstad O. 2004. Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin. Int J Cancer 112:475-483.
4. Black AR, Black JD, Azizkhan-Clifford J. 2001. Sp1 and kruppellike factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188:143-160.
5. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B. 2002. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40:1155-1163.
6. Chae JI, Jeon YJ, Shim JH. 2013. Downregulation of Sp1 is involved in honokiol-induced cell cycle arrest and apoptosis in human malignant pleural mesothelioma cells. Oncol Rep 29:2318-2324.
7. Chetoui N, Sylla K, Gagnon-Houde JV, et al. 2008. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Mol Cancer Res 6:42-52.
8. Chu S, Ferro TJ. 2005. Sp1: regulation of gene expression by phosphorylation. Gene 348:1-11.
9. Chuang JY, Wu CH, Lai MD, Chang WC, Hung JJ. 2009. Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells. Int J Cancer 125:2066-2076.
10. Deniaud E, Baguet J, Mathieu AL, Pages G, Marvel J, Leverrier Y. 2006. Overexpression of Sp1 transcription factor induces apoptosis. Oncogene 25:7096-7105.
11. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917.
12. Forastiere A, Koch W, Trotti A, Sidransky D. 2001. Head and neck cancer. N Engl J Med 345:1890-1900.
13. Gupta SC, Kim JH, Prasad S, Aggarwal BB. 2010. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29:405-434.
14. Hamada T, Wakamatsu T, Miyahara M, et al. 2012. MUC4: a novel prognostic factor of oral squamous cell carcinoma. Int J Cancer 130:1768-1776.
15. Higdon JV, Frei B. 2006. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46:101-123.
16. Hsieh PC, Jin YT, Chang CW, Huang CC, Liao SC, Yuan K. 2010. Elastin in oral connective tissue modulates the keratinization of overlying epithelium. J Clin Periodontol 37:705-711.
17. Ishibashi H, Nakagawa K, Onimaru M, et al. 2000. Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities. Cancer Res 60:6531-6536.
18. Jeon YJ, Ko SM, Cho JH, Chae JI, Shim JH. 2013. The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma. Int J Mol Med 32:860-866.
19. Kavurma MM, Khachigian LM. 2003. Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation. J Biol Chem 278:32537-32543.
20. Kim DW, Ko SM, Jeon YJ, et al. 2013. Anti-proliferative effect of honokiol in oral squamous cancer through the regulation of specificity protein 1. Int J Oncol 43:1103-1110.
21. Kim JY, Jung KS, Jeong HG. 2004a. Suppressive effects of the kahweol and cafestol on cyclooxygenase-2 expression in macrophages. FEBS Lett 569:321-326.
22. Kim JY, Jung KS, Lee KJ, et al. 2004b. The coffee diterpene kahweol suppress the inducible nitric oxide synthase expression in macrophages. Cancer Lett 213:147-154.
23. Knappskog S, Lonning PE. 2011. Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk. Transcription 2:207-210.
24. Kong LM, Liao CG, Fei F, Guo X, Xing JL, Chen ZN. 2010. Transcription factor Sp1 regulates expression of cancerassociated molecule CD147 in human lung cancer. Cancer Sci 101:1463-1470.
25. Li F. 2003. Survivin study: what is the next wave? J Cell Physiol 197:8-29.
26. Li L, Davie JR. 2010. The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat 192:275-283.
27. Mashberg A, Boffetta P, Winkelman R, Garfinkel L. 1993. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U. S. veterans. Cancer 72:1369-1375.
28. Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, Gutkind JS. 2009. Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 45:324-334.
29. Murray AW 2004. Recycling the cell cycle: cyclins revisited. Cell 116:221-234.
30. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. 2011. Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11:558-572.
31. Neville BW, Day TA. 2002. Oral cancer and precancerous lesions. CA Cancer J Clin 52:195-215.
32. Safe S, Abdelrahim M. 2005. Sp transcription factor family and its role in cancer. Eur J Cancer 41:2438-2448.
33. Sankpal UT, Goodison S, Abdelrahim M, Basha R. 2011. Targeting Sp1 transcription factors in prostate cancer therapy. Med Chem 7:518-525.
34. Sherr CJ, Roberts JM. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
35. Spiller MA. 1984. The chemical components of coffee. Prog Clin Biol Res 158:91-147.
36. Tao KS, Wang W, Wang L, et al. 2008. The multifaceted mechanisms for coffee's anti-tumorigenic effect on liver. Med Hypotheses 71:730-736.
37. Tuomilehto J. 2013. [Coffee and health]. Duodecim 129:1398-1405.
38. Warnakulasuriya S. 2009. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309-316.
39. Wei SH, Dong K, Lin F, et al. 2008. Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell. Cancer Chemother Pharmacol 62:1055-1064.
40. Weinstein IB. 1996. Relevance of cyclin D1 and other molecular markers to cancer chemoprevention. J Cell Biochem Suppl 25:23-28.
41. Xu R, Zhang P, Huang J, Ge S, Lu J, Qian G. 2007. Sp1 and Sp3 regulate basal transcription of the survivin gene. Biochem Biophys Res Commun 356:286-292.